Bile acids may hold clue to treat heart disease

December 6, 2011

Heart disease is a major cause of death in industrialised countries, and is strongly associated with obesity and diabetes. Many scientists believe that what links these conditions is a chronic, low-grade inflammation. The current study, published in the scientific journal Cell Metabolism (December 6, 2011), supports that theory by demonstrating that a modified bile acid called INT-777 prevents atherosclerosis, the build-up of fatty plaques in the walls of arteries, and a leading cause of heart disease—and that it does so by exerting an anti-inflammatory effect.

INT-777 activates a receptor in the membrane of gut cells called TGR5, and in so doing enhances the secretion of a hormone called Glucagon-Like Peptide-1 (GLP-1). GLP-1 is normally induced by feeding, and it stimulates insulin secretion in response to glucose. In earlier work, Profs Kristina Schoonjans and Johan Auwerx of the EPFL's Laboratory of Integrative Systems Physiology (LISP), in collaboration with Prof Roberto Pellicciari of the University of Perugia (Italy) and Intercept Pharmaceuticals (New York, USA), found that they could protect mice fed a high-fat diet from and diabetes by supplementing their food with INT-777.

Anti-diabetic drugs already exist that prolong the activity of GLP-1 in the body. The EPFL group's discovery that INT-777 enhances GLP-1 secretion raised the exciting prospect of combining the two therapeutic approaches for a more effective treatment of diabetes. But how would INT-777 affect any underlying , and in particular, atherosclerosis?

To find out, LISP members Dr Thijs Pols and Mitsunori Nomura treated mice prone to atherosclerosis with INT-777, and found a significant reduction in plaque formation. Atherosclerotic plaques contain inflammatory cells called macrophages that are generated in the bone marrow. When the bone marrow of the atherosclerosis-prone mice was replaced by bone marrow from either healthy, wild-type mice, or from mice genetically engineered to lack TGR5, the researchers found that only those that received the wild-type marrow showed significantly reduced plaque formation following INT777 treatment. "That was the evidence we needed that it was the anti-inflammatory effect of the compound, acting via TGR5 in bone marrow-derived cells, that accounted for the protective effect," says Dr Schoonjans.

INT777 therefore looks like a promising candidate for the treatment of metabolic syndrome, she says. Unlike some existing anti-diabetes drugs, it is unlikely to have the side-effect of hypoglycaemia, or very low blood glucose, because it only triggers GLP-1 secretion when glucose is in sufficient supply. And though its anti-inflammatory effects are significant, they are moderate, meaning that it would be unlikely to interfere with the normal immune response. The next step will be to devise clinical trials, to test its safety and efficacy in humans.

Explore further: Research reveals hormone action that could lead to treatments for type 2 diabetes

Related Stories

Research reveals hormone action that could lead to treatments for type 2 diabetes

September 30, 2011
(Medical Xpress) -- Researchers at the University of Cincinnati have discovered that the immediate improvement in blood sugar (blood glucose) for those with type 2 diabetes who undergo gastric bypass surgery is related to ...

Substance in tangerines fights obesity and protects against heart disease

April 6, 2011
New research from The University of Western Ontario has discovered a substance in tangerines not only prevents obesity, but also offers protection against type 2 diabetes, and even atherosclerosis, the underlying disease ...

Recommended for you

How genes and environment interact to raise risk of congenital heart defects

October 19, 2017
Infants of mothers with diabetes have a three- to five-fold increased risk of congenital heart defects. Such developmental defects are likely caused by a combination of genetic and environmental factors. However, the molecular ...

Mouse studies shed light on how protein controls heart failure

October 18, 2017
A new study on two specially bred strains of mice has illuminated how abnormal addition of the chemical phosphate to a specific heart muscle protein may sabotage the way the protein behaves in a cell, and may damage the way ...

Newborns with trisomy 13 or 18 benefit from heart surgery, study finds

October 18, 2017
Heart surgery significantly decreases in-hospital mortality among infants with either of two genetic disorders that cause severe physical and intellectual disabilities, according to a new study by a researcher at the Stanford ...

Saving hearts after heart attacks: Overexpression of a gene enhances repair of dead muscle

October 17, 2017
University of Alabama at Birmingham biomedical engineers report a significant advance in efforts to repair a damaged heart after a heart attack, using grafted heart-muscle cells to create a repair patch. The key was overexpressing ...

Physically active white men at high risk for plaque buildup in arteries

October 17, 2017
White men who exercise at high levels are 86 percent more likely than people who exercise at low levels to experience a buildup of plaque in the heart arteries by middle age, a new study suggests.

High blood pressure linked to common heart valve disorder

October 17, 2017
For the first time, a strong link has been established between high blood pressure and the most common heart valve disorder in high-income countries, by new research from The George Institute for Global Health at the University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.